Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHERYL KIRK MORRISEY

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1104943893
CMS profile
1278010
Location
BRANDON, FL

General Payments · PY2021–2024

$2,908.52

  • Reported across 131 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,088.00

57 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,088.00 57

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $336.46 12
Novo Nordisk AS $163.39 11
Lilly USA, LLC $146.04 11
Boehringer Ingelheim Pharmaceuticals, Inc. $108.93 5
ABBVIE INC. $102.19 5
Exact Sciences Corporation $60.78 3
GlaxoSmithKline, LLC. $44.84 3
Grifols USA, LLC $38.01 2
PFIZER INC. $34.26 2
Sumitomo Pharma America, Inc. $22.74 1
Mylan Specialty L.P. $16.86 1
EISAI INC. $13.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $329.57 13
PY2022 $702.42 25
PY2023 $788.53 36
PY2024 $1,088.00 57

Payment records · PY2024 (57)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $28.62 01/19/2024 Food and Beverage Undisputed 01/23/2026 1107469381 CMS
ABBVIE INC. $17.33 03/01/2024 Food and Beverage Undisputed 01/23/2026 1107469383 CMS
ABBVIE INC. $19.49 04/30/2024 Food and Beverage Undisputed 01/23/2026 1107469385 CMS
ABBVIE INC. $16.30 06/04/2024 Food and Beverage Undisputed 01/23/2026 1107469387 CMS
ABBVIE INC. $20.45 07/22/2024 Food and Beverage Undisputed 01/23/2026 1107469389 CMS
AstraZeneca Pharmaceuticals LP $24.38 01/30/2024 Food and Beverage Undisputed 01/23/2026 1105830715 CMS
AstraZeneca Pharmaceuticals LP $14.16 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105793788 CMS
AstraZeneca Pharmaceuticals LP $19.49 03/25/2024 Food and Beverage Undisputed 01/23/2026 1105273727 CMS
AstraZeneca Pharmaceuticals LP $25.97 03/29/2024 Food and Beverage Undisputed 01/23/2026 1104626788 CMS
AstraZeneca Pharmaceuticals LP $22.74 04/21/2024 Food and Beverage Undisputed 01/23/2026 1104756232 CMS
AstraZeneca Pharmaceuticals LP $120.89 05/16/2024 Food and Beverage Undisputed 01/23/2026 1104682447 CMS
AstraZeneca Pharmaceuticals LP $14.01 06/07/2024 Food and Beverage Undisputed 01/23/2026 1105895960 CMS
AstraZeneca Pharmaceuticals LP $28.29 07/10/2024 Food and Beverage Undisputed 01/23/2026 1105482027 CMS
AstraZeneca Pharmaceuticals LP $14.38 08/05/2024 Food and Beverage Undisputed 01/23/2026 1104261395 CMS
AstraZeneca Pharmaceuticals LP $18.36 09/16/2024 Food and Beverage Undisputed 01/23/2026 1104517528 CMS
AstraZeneca Pharmaceuticals LP $16.42 11/20/2024 Food and Beverage Undisputed 01/23/2026 1105672915 CMS
AstraZeneca Pharmaceuticals LP $17.37 12/16/2024 Food and Beverage Undisputed 01/23/2026 1105500768 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.62 02/15/2024 Food and Beverage Undisputed 01/23/2026 1117875825 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.22 03/12/2024 Food and Beverage Undisputed 01/23/2026 1117875821 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.60 05/02/2024 Food and Beverage Undisputed 01/23/2026 1117875823 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.59 07/29/2024 Food and Beverage Undisputed 01/23/2026 1117875819 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.90 10/24/2024 Food and Beverage Undisputed 01/23/2026 1117875817 CMS
Eisai Inc. $13.50 11/19/2024 Food and Beverage Undisputed 01/23/2026 1110821473 CMS
Exact Sciences Corporation $19.66 03/06/2024 Food and Beverage Undisputed 01/23/2026 1114736703 CMS
Exact Sciences Corporation $20.90 07/09/2024 Food and Beverage Undisputed 01/23/2026 1114736709 CMS
Exact Sciences Corporation $20.22 08/20/2024 Food and Beverage Undisputed 01/23/2026 1114736715 CMS
GlaxoSmithKline, LLC. $14.90 08/06/2024 Food and Beverage Undisputed 01/23/2026 1116563752 CMS
GlaxoSmithKline, LLC. $15.11 10/01/2024 Food and Beverage Undisputed 01/23/2026 1116640632 CMS
GlaxoSmithKline, LLC. $14.83 11/12/2024 Food and Beverage Undisputed 01/23/2026 1116470740 CMS
Grifols USA, LLC $17.19 08/27/2024 Food and Beverage Undisputed 01/23/2026 1124733165 CMS
Grifols USA, LLC $20.82 12/02/2024 Food and Beverage Undisputed 01/23/2026 1124733167 CMS
Lilly USA, LLC $13.71 02/08/2024 Food and Beverage Undisputed 01/23/2026 1135941108 CMS
Lilly USA, LLC $12.07 08/13/2024 Food and Beverage Undisputed 01/23/2026 1135909997 CMS
Lilly USA, LLC $2.81 08/22/2024 Food and Beverage Undisputed 01/23/2026 1135909995 CMS
Lilly USA, LLC $3.37 08/22/2024 Food and Beverage Undisputed 01/23/2026 1135954181 CMS
Lilly USA, LLC $17.17 09/06/2024 Food and Beverage Undisputed 01/23/2026 1135865860 CMS
Lilly USA, LLC $30.93 10/08/2024 Food and Beverage Undisputed 01/23/2026 1135865864 CMS
Lilly USA, LLC $15.50 10/08/2024 Food and Beverage Undisputed 01/23/2026 1135909999 CMS
Lilly USA, LLC $19.48 10/31/2024 Food and Beverage Undisputed 01/23/2026 1135941110 CMS
Lilly USA, LLC $13.18 12/03/2024 Food and Beverage Undisputed 01/23/2026 1135964774 CMS
Lilly USA, LLC $0.51 12/03/2024 Food and Beverage Undisputed 01/23/2026 1135964776 CMS
Lilly USA, LLC $17.31 12/12/2024 Food and Beverage Undisputed 01/23/2026 1135964772 CMS
Mylan Specialty L.P. $16.86 01/09/2024 Food and Beverage Undisputed 01/23/2026 1147306386 CMS
Novo Nordisk Inc $13.22 02/22/2024 Food and Beverage Undisputed 01/23/2026 1100272492 CMS
Novo Nordisk Inc $19.03 04/04/2024 Food and Beverage Undisputed 01/23/2026 1100328648 CMS
Novo Nordisk Inc $18.16 06/13/2024 Food and Beverage Undisputed 01/23/2026 1100418339 CMS
Novo Nordisk Inc $12.85 07/11/2024 Food and Beverage Undisputed 01/23/2026 1100387733 CMS
Novo Nordisk Inc $17.77 08/12/2024 Food and Beverage Undisputed 01/23/2026 1100406708 CMS
Novo Nordisk Inc $10.35 09/10/2024 Food and Beverage Undisputed 01/23/2026 1100242676 CMS
Novo Nordisk Inc $20.11 10/14/2024 Food and Beverage Undisputed 01/23/2026 1100588471 CMS
Novo Nordisk Inc $6.89 10/24/2024 Food and Beverage Undisputed 01/23/2026 1100353178 CMS
Novo Nordisk Inc $16.64 11/05/2024 Food and Beverage Undisputed 01/23/2026 1100382809 CMS
Novo Nordisk Inc $17.11 11/25/2024 Food and Beverage Undisputed 01/23/2026 1100232832 CMS
Novo Nordisk Inc $11.26 12/09/2024 Food and Beverage Undisputed 01/23/2026 1100339110 CMS
PFIZER INC. $15.23 07/02/2024 Food and Beverage Undisputed 01/23/2026 1131750372 CMS
PFIZER INC. $19.03 10/15/2024 Food and Beverage Undisputed 01/23/2026 1130878422 CMS
Sumitomo Pharma America, Inc. $22.74 10/29/2024 Food and Beverage Undisputed 01/23/2026 1148972644 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.